186 related articles for article (PubMed ID: 33137361)
1. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
Li Y; Li P; Li Y; Zhang R; Yu P; Ma Z; Kainov DE; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Dec; 184():104967. PubMed ID: 33137361
[TBL] [Abstract][Full Text] [Related]
2. IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genes.
Xu L; Zhou X; Wang W; Wang Y; Yin Y; Laan LJ; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
FASEB J; 2016 Oct; 30(10):3352-3367. PubMed ID: 27328944
[TBL] [Abstract][Full Text] [Related]
3. Suppression of interferon-α signaling by hepatitis E virus.
Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
[TBL] [Abstract][Full Text] [Related]
4. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
[TBL] [Abstract][Full Text] [Related]
5. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
[TBL] [Abstract][Full Text] [Related]
6. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.
Todt D; François C; Anggakusuma ; Behrendt P; Engelmann M; Knegendorf L; Vieyres G; Wedemeyer H; Hartmann R; Pietschmann T; Duverlie G; Steinmann E
Antimicrob Agents Chemother; 2016 Apr; 60(4):2132-9. PubMed ID: 26787701
[TBL] [Abstract][Full Text] [Related]
8. Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replication.
Wang W; Wang Y; Debing Y; Zhou X; Yin Y; Xu L; Herrera Carrillo E; Brandsma JH; Poot RA; Berkhout B; Neyts J; Peppelenbosch MP; Pan Q
Antiviral Res; 2017 Apr; 140():1-12. PubMed ID: 28077314
[TBL] [Abstract][Full Text] [Related]
9. MDA5 against enteric viruses through induction of interferon-like response partially via the JAK-STAT cascade.
Li Y; Yu P; Qu C; Li P; Li Y; Ma Z; Wang W; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Apr; 176():104743. PubMed ID: 32057771
[TBL] [Abstract][Full Text] [Related]
10. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
11. The macrolide antibiotic azithromycin potently inhibits hepatitis E virus in cell culture models.
Miao Z; Zhang R; Yu P; Li Y; Pan Q; Li Y
Int J Antimicrob Agents; 2021 Sep; 58(3):106383. PubMed ID: 34157403
[TBL] [Abstract][Full Text] [Related]
12. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
14. Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.
Dang W; Xu L; Ma B; Chen S; Yin Y; Chang KO; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104275
[TBL] [Abstract][Full Text] [Related]
15. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
[TBL] [Abstract][Full Text] [Related]
16. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection.
Zhou X; Xu L; Wang W; Watashi K; Wang Y; Sprengers D; de Ruiter PE; van der Laan LJ; Metselaar HJ; Kamar N; Peppelenbosch MP; Pan Q
J Viral Hepat; 2016 Apr; 23(4):294-304. PubMed ID: 26620360
[TBL] [Abstract][Full Text] [Related]
17. Screening of novel drugs for inhibiting hepatitis E virus replication.
Nishiyama T; Kobayashi T; Jirintai S; Kii I; Nagashima S; Prathiwi Primadharsini P; Nishizawa T; Okamoto H
J Virol Methods; 2019 Aug; 270():1-11. PubMed ID: 31004661
[TBL] [Abstract][Full Text] [Related]
18. The Amino-Terminal Region of Hepatitis E Virus ORF1 Containing a Methyltransferase (Met) and a Papain-Like Cysteine Protease (PCP) Domain Counteracts Type I Interferon Response.
Bagdassarian E; Doceul V; Pellerin M; Demange A; Meyer L; Jouvenet N; Pavio N
Viruses; 2018 Dec; 10(12):. PubMed ID: 30567349
[TBL] [Abstract][Full Text] [Related]
19. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
20. Pseudorabies Virus Inhibits Type I and Type III Interferon-Induced Signaling via Proteasomal Degradation of Janus Kinases.
Yin Y; Romero N; Favoreel HW
J Virol; 2021 Sep; 95(20):e0079321. PubMed ID: 34379505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
